The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
In vivo synergism between PARP-inhibitor olaparib and HSP90-inhibitor AT13387 in high grade serous ovarian cancer patient derived xenografts.
 
Panagiotis Konstantinopoulos
Consulting or Advisory Role - Vertex
 
Sangeetha Palakurthi
Research Funding - Array BioPharma (Inst); AstraZeneca (Inst); Janssen-Ortho (Inst)
 
Qing Zeng
Research Funding - AstraZeneca (Inst)
 
Shan Zhou
Research Funding - AstraZeneca (Inst)
 
Joyce F. Liu
Consulting or Advisory Role - AstraZeneca; Genentech/Roche
Research Funding - AstraZeneca (Inst); Atara Biotherapeutics (Inst); Boston Biomedical (Inst); Genentech/Roche (Inst); Merrimack (Inst)
 
Elena Ivanova
No Relationships to Disclose
 
Cloud Paweletz
Honoraria - Bio-Rad; Clovis Oncology
Patents, Royalties, Other Intellectual Property - Pending patent cf DNA genotyping
Travel, Accommodations, Expenses - Bio-Rad
 
Naveen Kommajosyula
No Relationships to Disclose
 
Alan D. D'Andrea
Honoraria - Lilly
Consulting or Advisory Role - Lilly
Travel, Accommodations, Expenses - Lilly
 
Geoffrey Shapiro
Consulting or Advisory Role - Chugai Pharma; EMD Serono; G1 Therapeutics; Lilly; Takeda; Tesaro; Vertex
Research Funding - Aileron Therapeutics (Inst); AstraZeneca (Inst); Bayer (Inst); Cellceutix (Inst); Covidien (Inst); Cyclacel (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Immune Design (Inst); Lilly; Millennium (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); PTC Therapeutics (Inst); Puma Biotechnology (Inst); Sanofi (Inst); Tensha Therapeutics (Inst); Vertex (Inst)
 
Ursula A. Matulonis
Consulting or Advisory Role - AstraZeneca; Genentech; Immunogen; Merck KGaA; Tesaro